OM DETTA AVSNITT

Engelsk
USA

UTSKRIFT 🔗

SÖK TIDIGARE AVSNITT

Sök efter tidigare avsnitt från Beyond The Script.

ANDRA EPISODER I DENNA PODCAST

EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation. Key topics include: - Why the UK's medical…
EP5 - Join COO of Releaf, Graham Woodward, and Dr Anne Katrin Schlag, Head of Research at Drug Science, as they explore how the UK can move from anecdotal patient stories to real-world evidence, and why this shift is vital for expanding safe, trusted access to cannabis-based medicines. Let's rethin…
EP1 - CEOs Tim Kirby of Releaf and James Duckenfield of Glass Pharm sat down to discuss the ever-evolving UK medical cannabis sector. In 2024, we joined forces with Glass Pharms in the UK's largest ever medical cannabis deal, providing Releaf patients with a consistent, high-quality supply of…
EP4 - Tim Kirby, CEO of Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals discuss strategies for expanding the medical cannabis market in the UK. They highlight the challenges in the current market, such as patient accessibility and supply chain issues, emph…
Ansvarsfriskrivning: Podcasten och konstverket som är inbäddat på den här sidan är från Releaf, som är dess ägares egendom och inte anslutet till eller godkänt av Listen Notes, Inc.